v3.26.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Millions
3 Months Ended
Mar. 28, 2026
Mar. 29, 2025
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net income/(loss) $ 799 $ 714
Adjustments to reconcile net income/(loss) to operating cash flows:    
Depreciation and amortization 245 231
Divestiture-related license income (13) (13)
Equity award compensation expense 22 27
Deferred income tax provision/(benefit) 29 51
Postemployment benefit plan contributions (4) (4)
Goodwill and intangible asset impairment losses 13 0
Nonmonetary currency devaluation 12 14
Loss/(gain) on sale of business (3) 0
Other items, net (227) (14)
Changes in current assets and liabilities:    
Trade receivables (73) (89)
Inventories (195) (217)
Accounts payable 256 (11)
Other current assets 3 (47)
Other current liabilities 142 78
Net cash provided by/(used for) operating activities 1,006 720
CASH FLOWS FROM INVESTING ACTIVITIES:    
Capital expenditures (240) (238)
Purchases of marketable securities (105) (673)
Proceeds from sale of marketable securities 387 0
Proceeds from sale of business, net of cash disposed and working capital adjustments 146 9
Other investing activities, net (3) 24
Net cash provided by/(used for) investing activities 185 (878)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Proceeds from issuance of long-term debt 0 1,620
Dividends paid (474) (477)
Repurchases of common stock (23) (225)
Other financing activities, net (15) (18)
Net cash provided by/(used for) financing activities (512) 900
Effect of exchange rate changes on cash, cash equivalents, and restricted cash (7) 35
Cash, cash equivalents, and restricted cash    
Net increase/(decrease) 672 777
Balance at beginning of period 2,944 1,486
Balance at end of period $ 3,616 $ 2,263